Shanghai Xinzhi BioMed Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shanghai Xinzhi BioMed Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease (NCT07195825) | Shanghai Xinzhi BioMed Co., Ltd. | 2025-12-27 |
| Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs (NCT06111638) | Shanghai Xinzhi BioMed Co., Ltd. | 2024-01-03 |
| Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug (NCT05203679) | Shanghai Xinzhi BioMed Co., Ltd. | 2021-12-30 |
Track Shanghai Xinzhi BioMed Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.